ArticleArthroplasty (London, England)2026
Clinical outcomes and perioperative safety of primary total knee arthroplasty for hemophilic arthropathy versus osteoarthritis: a retrospective cohort study.
Article in Arthroplasty (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundHemophilic arthropathy (HAr) frequently progresses to end-stage joint disease requiring total knee arthroplasty (TKA), but coagulation dysfunction raises concerns about perioperative bleeding and complications. We aim to analyze the clinical outcomes and safety associated with primary TKA in patients with HAr.
methodsThis single-center retrospective cohort included 22 TKAs in 20 men with HAr and 66 TKAs in 66 male osteoarthritis (OA) controls selected by surgeon and proximity of surgery date. The procedure was the analysis unit, and standard errors were clustered by patient. Continuous outcomes were compared with Welch tests and adjusted using baseline-outcome analysis of covariance including group, age, and body mass index. Sparse binary outcomes were exploratory and analyzed with Fisher exact tests and Firth logistic regression. Calculated blood loss was evaluated using the Nadler-Gross method.
resultsPatients with HAr were younger (41.86 ± 11.29 versus 68.33 ± 6.70 years). Mean improvement in the Knee Society clinical score was 49.64 ± 18.43 versus 53.24 ± 5.77 points (unadjusted between-group change-score difference, - 3.61; 95% CI - 11.88 to 4.67; p = 0.376). Adjusted 12-month group effects were 0.54 points (95% CI - 4.19 to 5.28; p = 0.820) for Knee Society clinical score and 3.02 points (95% CI - 9.73 to 15.77; p = 0.639) for Knee Society function while adjusted flexion remained lower (mean difference, - 19.64°; 95% CI - 38.29° to - 0.99°; p = 0.039). Calculated blood loss did not differ significantly (532.53 ± 355.18 versus 628.00 ± 328.38 mL; p = 0.275), while transfusion occurred in 4/22 versus 0/66 procedures (p = 0.003). Wound problems (6/22 versus 3/66) and 90-day readmissions (9/22 versus 1/66) were more frequent in crude comparisons, but adjusted estimates were highly imprecise.
conclusionsUnder comprehensive blood management, TKA produced substantial within-group functional improvement in HAr. Adjusted 12-month Knee Society clinical and function scores were not detectably different, although flexion remained lower. Calculated blood loss was not increased, but transfusion and unadjusted wound or readmission signals warrant multidisciplinary care and confirmation in larger, prospectively defined cohorts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.